Our Recommendations
- Skin NTDs App (2024)
- Operational manual on indoor residual spraying: Control of vectors of malaria, Aedes-borne diseases, Chagas disease, leishmaniases and lymphatic filariasis (2024)
- Guideline for the Treatment of Leishmaniasis in the Americas (2022)
- Post-Kala-Azar Dermal Leishmaniasis: A Manual for Case Management and Control (2013)
- Standard operating procedures for supply chain management of health products for neglected tropical diseases amenable to preventive chemotherapy (2022)
New Publications
- Operational manual on indoor residual spraying: Control of vectors of malaria, Aedes-borne diseases, Chagas disease, leishmaniases and lymphatic filariasis (2024)
- Protocolos de Vigilancia Epidemiológica Enfermedades Vectoriales de Origen Parasitario (2018)
- Elimination of kala-azar as a public health problem in South-East Asia: template dossier (2025)
- Élimination de la leishmaniose viscérale en tant que problème de santé publique au Kenya – progrès et défis (2024)
- Skin NTDs App (2024)
Filter
85
Featured
Recommendations
5
New Publications
2
Language
Document type
Studies & Reports
21
Videos
16
Resource Platforms
15
Guidelines
11
Manuals
5
Infographics
5
Fact sheets
5
Strategic & Response Plan
4
Training Material
1
Dashboards/Maps
1
App
1
Countries / Regions
Global
33
Latin America and the Carribbean
9
Middle East and North Africa
4
Brazil
3
Sudan
3
Colombia
2
Kenya
2
South–East Asia Region
2
Bangladesh
2
Ethiopia
2
South Sudan
2
Somalia
2
India
2
Nepal
1
Turkey
1
China
1
Syria
1
Iran
1
Albania
1
Morocco
1
Africa
1
Asia
1
Jordan
1
Saudi Arabia
1
Western and Central Europe
1
Paraguay
1
Tunisia
1
East and Southern Africa
1
Bolivia
1
Lebanon
1
Eastern Europe
1
Greece
1
Georgia
1
Iraq
1
Pakistan
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
18
Countries
10
Public Health
6
Pharmacy & Technologies
2
Key Resources
1
This technical report presents the epidemiology of human and animal leishmaniases in the EU and its neighbouring countries and concludes that the disease remains widespread and underreported in many countries of southern Europe, northern Africa, and the Middle East and that there is a need to improv...
High prevalence of target diseases in rural and developing nations, increased prevalence of malnutrition across the globe, lack of hygiene and poor sanitation facilities, Migratory patterns of population, introduction of new chemical entity in the field of therapeutics, favorable government regulati...
Cutaneous leishmaniasis (CL) is a parasitic disease caused by infection with a vector-borne protozoan parasite of the genus Leishmania spp. The parasite is transmitted by the bite of an infected phlebotomine sand fly. Infection results in skin lesions which take a long time to heal and may leave per...
Cutaneous leishmaniasis (CL) is a neglected infectious endemic disease that is transmitted through the bite of a vector insect (sandfly) of the Lutzomyia genus,typical of rural geographical territories, and causes disfiguring skin ulcers and disabilities. It is estimated that CL affects between 600 ...
Die Infektion wird durch nachtaktive, blutsaugende Raubwanzen übertragen. Während des Blutsaugens scheiden die infizierten Wanzen Trypanosomen aus, die Bindehaut, Schleimhäute, Abschürfungen und Hautverletzungen einschließlich der Bißwunde kontaminieren können. Die Übertragung kann auch durc...
Leishmaniasis is a vector-borne disease with a wide variety of parasite species, reservoirs, and vectors involved in transmission. It is caused by different species of the protozoa Leishmania and is transmitted to animals and humans through a bite of insects in the Psychodidae family. Its presence i...
We developed an integrated vector surveillance (IVS) proposal for cutaneous leishmaniasis (CL) and visceral leishmaniasis (VL) in the Americas, based on eco-epidemiological studies conducted by researchers of the Leishmaniasis Research Network of Argentina. For CL, the transmission was explained in ...
Leishmaniasis is a complex vector-borne disease involving in its transmission several species of protozoan parasites called Leishmania, a wide variety of animal reservoirs and phlebotomine sandflies vectors. Cutaneous Leishmaniasis (CL) is the most common form of the disease, and its clinical manife...
Localized cutaneous leishmaniasis and its evolving forms (diffuse cutaneous leishmaniasis, mucosal leishmaniasis and cutaneous leishmaniasis recidivans), together with the sequela of visceral leishmaniasis (post-kala-azar dermal leishmaniasis), account for about one million cases of dermal leishmani...
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Leishmania species for which there is strong evidence for the efficacy of miltefosine has increased from ...
Leishmaniasis is a climate-sensitive disease. Changes in temperature, rainfall, and humidity can have strong impacts on
the sandfly vector, altering their distribution and influencing their survival and population sizes. Increased temperatures shorten vector development time, reduce Leishmania para...
We reviewed the evidence on community-based interventions for the prevention and control of cutaneous leishmaniasis (CL). Community initiatives tailored towards awareness and mobilisation are regarded as a priority area in the Neglected Tropical Disease Roadmap 2021–2030 by the World Health Organi...
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with...
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported ...
In the Indian state of Bihar, visceral leishmaniasis (VL) is a major public health issue that has been aggravated by the rising incidence of new Human immunodeficiency virus (HIV) infections. In endemic areas, the risk of VL infections in patients living with HIV (PLHIV) is higher. It is important t...
In the Region of the Americas, the leishmaniases are a group of diseases caused by various species of Leishmania, which cause a set of clinical syndromes in infected humans that can involve the skin, mucosa, and visceral organs. The spectrum of clinical disease is varied and depends on the interacti...
Cutaneous leishmaniasis is a painful disease that exerts a serious toll on societies around the world that are afflicted by it. Although not life-threatening, the skin ulcers and scars it causes can lead to isolation and psychosocial pathologies due to social stigma, and its occurrence is often asso...
Leishmaniasis is still considered to be a global health problem, which spreads in most countries in the world. Leishmania is an intracellular obligate protistan parasite that causes different clinical symptoms in infected humans and other animals. There are clinically different types of the disease ...
Front Chem. 2021; 9: 622286.
Published online 2021 Mar 12. doi: 10.3389/fchem.2021.622286
J Glob Health Sci. 2020 Jun;2(1):e3. A group of enzootic and zoonotic protozoan infections, the leishmaniases constitute among the most severely neglected tropical diseases (NTDs) and are found in all continents except Oceania. Representing the most common infectious diseases, NTDs comprise an open-...
